
- /
- Supported exchanges
- / US
- / CMND.NASDAQ
Clearmind Medicine Inc. Common Shares (CMND NASDAQ) stock market data APIs
Clearmind Medicine Inc. Common Shares Financial Data Overview
Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. The company develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, it has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; Yissum Research Development Company of the Hebrew University of Jerusalem to develop, manufacture, and commercialize compounds targeted at treating post traumatic stress disorder and other health conditions. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is based in Vancouver, Canada.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Clearmind Medicine Inc. Common Shares data using free add-ons & libraries
Get Clearmind Medicine Inc. Common Shares Fundamental Data
Clearmind Medicine Inc. Common Shares Fundamental data includes:
- Net Revenue:
- EBITDA: -5 849 668
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-12
- EPS/Forecast: NaN
Get Clearmind Medicine Inc. Common Shares End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Clearmind Medicine Inc. Common Shares News

Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial
(RTTNews) - Clearmind Medicine Inc. (CMND), a clinical-stage biotech company developing psychedelic-derived treatments, has received Institutional Review Board or IRB approval from Tel Aviv Sourasky M...


Sector Update: Health Care Stocks Mixed Thursday Afternoon
Health care stocks were mixed Thursday afternoon, with the NYSE Health Care Index down 0.1% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center
Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery an...

Clearmind doses first participant in alcohol disorder treatment trial
VANCOUVER - Clearmind Medicine Inc. (NASDAQ:CMND), a micro-cap biotech company with a market capitalization of $4.56 million, has dosed the first participant with its MEAI-based oral drug candidate CM...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.